EP Patent

EP0974351A3 — Medicament for preventing and treating gastrointestinal damage

Assigned to Jouveinal SA · Expires 2000-12-13 · 25y expired

What this patent protects

GABA analogs are useful to prevent and treat gastrointestinal damage and ethanol withdrawal syndrome. Preferred treatments employ gabapentin or pregabalin.

USPTO Abstract

GABA analogs are useful to prevent and treat gastrointestinal damage and ethanol withdrawal syndrome. Preferred treatments employ gabapentin or pregabalin.

Drugs covered by this patent

safinamide-mesylate (SAFINAMIDE MESYLATE)

Patent Metadata

Patent number: EP0974351A3
Jurisdiction: EP
Classification: —
Expires: 2000-12-13
Drug substance claim: No
Drug product claim: No
Assignee: Jouveinal SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.